Molecular variants of SARS‑CoV‑2: antigenic properties and current vaccine efficacy

Damavandi, Amirmasoud Rayati and Dowran, Razieh and Al Sharif, Sarah and Kashanchi, Fatah and Jafari, Reza Molecular variants of SARS‑CoV‑2: antigenic properties and current vaccine efficacy. Medical Microbiology and Immunology.

[img] Text
2564.pdf

Download (2MB)

Abstract

An ongoing pandemic of newly emerged SARS-CoV-2 has puzzled many scientists and health care policymakers around the globe. The appearance of the virus was accompanied by several distinct antigenic changes, specifically spike protein which is a key element for host cell entry of virus and major target of currently developing vaccines. Some of these mutations enable the virus to attach to receptors more firmly and easily. Moreover, a growing number of trials are demonstrating higher transmissibility and, in some of them, potentially more serious forms of illness related to novel variants. Some of these lineages, especially the Beta variant of concern, were reported to diminish the neutralizing activity of monoclonal and polyclonal antibodies present in both convalescent and vaccine sera. This could imply that these independently emerged variants could make antiviral strategies prone to serious threats. The rapid changes in the mutational profile of new clades, especially escape mutations, suggest the convergent evolution of the virus due to immune pressure. Nevertheless, great international efforts have been dedicated to producing efficacious vaccines with cutting-edge technologies. Despite the partial decrease in vaccines efficacy against worrisome clades, most current vaccines are still effective at preventing mild to severe forms of disease and hospital admission or death due to coronavirus disease 2019 (COVID-19). Here, we summarize existing evidence about newly emerged variants of SARS-CoV-2 and, notably, how well vaccines work against targeting new variants and modifications of highly flexible mRNA vaccines that might be required in the future.

Item Type: Article
Uncontrolled Keywords: Escape mutations · Neutralizing activity · SARS-CoV-2 · COVID-19 · Spike protein · Vaccines efficacy · Variants of concern
Subjects: R Medicine > R Medicine (General)
Depositing User: Unnamed user with email gholipour.s@umsu.ac.ir
Date Deposited: 05 Nov 2022 08:08
Last Modified: 05 Nov 2022 08:08
URI: http://eprints.umsu.ac.ir/id/eprint/6426

Actions (login required)

View Item View Item